Gelofen in wisdom tooth surgery

Phase 2

• Conditions: Wisdom surgery.; Dental drugs, topically applied; Y56.7

• Registration Number: IRCT20181215041988N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Having an impacted mandibular wisdom tooth
Age between 14 and 65 years
Signature of consent

Exclusion Criteria

Systemic disease
Pregnancy
Drug abuse
Using anti_ analgesic grug

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: 2,4,6,12,24,48 hours after surgery. Method of measurement: visual analogue scale.

Secondary Outcome Measures

Name	Time	Method
Bleeding. Timepoint: 2 days after surgery. Method of measurement: questionnaire.;Swelling. Timepoint: 2 days after surgery. Method of measurement: Measured by ruler from comissure of lip_ lop of ear and countus of eye _ Angle of mandible.;Trismus. Timepoint: 2 days after surgery. Method of measurement: distance between the upper and lower incisal edges in millimeters.;Dry sucket. Timepoint: 2 days after surgery. Method of measurement: Examination.